Cite
UHPLC-ESI-MS/MS assay for quantification of endocannabinoids in cerebrospinal fluid using surrogate calibrant and surrogate matrix approaches.
MLA
Aydin, Ece, et al. “UHPLC-ESI-MS/MS Assay for Quantification of Endocannabinoids in Cerebrospinal Fluid Using Surrogate Calibrant and Surrogate Matrix Approaches.” Journal of Pharmaceutical and Biomedical Analysis, vol. 222, Jan. 2023, p. 115090. EBSCOhost, https://doi.org/10.1016/j.jpba.2022.115090.
APA
Aydin, E., Cebo, M., Mielnik, J., Richter, H., Schüle, R., Sievers-Engler, A., Młynarz, P., & Lämmerhofer, M. (2023). UHPLC-ESI-MS/MS assay for quantification of endocannabinoids in cerebrospinal fluid using surrogate calibrant and surrogate matrix approaches. Journal of Pharmaceutical and Biomedical Analysis, 222, 115090. https://doi.org/10.1016/j.jpba.2022.115090
Chicago
Aydin, Ece, Malgorzata Cebo, Justyna Mielnik, Hardy Richter, Rebecca Schüle, Adrian Sievers-Engler, Piotr Młynarz, and Michael Lämmerhofer. 2023. “UHPLC-ESI-MS/MS Assay for Quantification of Endocannabinoids in Cerebrospinal Fluid Using Surrogate Calibrant and Surrogate Matrix Approaches.” Journal of Pharmaceutical and Biomedical Analysis 222 (January): 115090. doi:10.1016/j.jpba.2022.115090.